Uroplakin III – RMab (Test2)

SKU: bbc1346654e2 Category:

3. Ihc Of Uroplakin Iii On A Ffpe Bladder Tcc Tissue- Webpage

IHC of Uroplakin III on an FFPE Bladder TCC Tissue

Uroplakin III, RMab

Catalog No.Antibody TypeDilutionVolume/QTY
BSB 3239PredilutedReady-To-Use3.0 ml
BSB 3240PredilutedReady-To-Use7.0 ml
BSB 3241PredilutedReady-To-Use15.0 ml
BSB 3242Concentrated1:50-1:2000.1 ml
BSB 3243Concentrated1:50-1:2000.5 ml
BSB 3244Concentrated1:50-1:2001.0 ml
BSB 3245Control Slides5
Note: For concentrated antibodies, please centrifuge prior to use to ensure recovery of all product.

Uroplakins (UPs) are a family of transmembrane proteins (UPs Ia, Ib, II and III) that are specific differentation products of urothelial cells. In non-neoplastic mammalian urothelium, UPs are expressed in the luminal surface plasmalemma of superficial (umbrella) cells, forming complexes of 16-nm crystalline particles. Uroplakin

III is expressed in urothelial carcinomas, whereas many non urothelial carcinomas were UPIII-negative. Recent studies have shown that UP expression might reflect the malignant potential of urothelial cancer cells as well as being cytodifferential markers of urothelial cells.

UPIII expression is strongly associated with lower tumor grades and lack of UPIII expression in urothelial tumors of the upper urinary tract is associated with much higher rates of metastases. Five-year specific survival is much worse for UPIII negative tumors (54%) than for UPIII positive tumors (100%). Apparently UPIII expression is a better indicator fo the malignant potential of the tumor than the grade of the tumor.

Intended UseFor In Vitro Diagnostic Use
Antibody TypeRabbit Monoclonal
ReactivityParaffin, Frozen
LocalizationCytoplasmic, Membranous
ControlBladder, Bladder Carcinoma

Uroplakin III is a rabbit monoclonal antibody derived from cell culture supernatant that is concentrated, dialyzed, filter sterilized and diluted in buffer pH 7.5, containing BSA and sodium azide as a preservative.

Download Spec Sheet

Download SDS Sheet

  1. Badalament RA, et al. J Urol. 1990; 144:859-63
  2. Hall MC, et al. Urology. 1998; 52:594-601
  3. Ohtsuka Y, et al. BJU Int. 2006 Jun; 97(6):1322-6
  4. Oldsburgh J, et al. J Pathol. 2003; 199:41-9
  5. U.S. Department of Health and Human Services:  Centers for Disease Control and Prevention.  Guidelines for Safe Work Practices in Human and Animal Medical Diagnostic Laboratories.  Supplement / Vol. 61, January 6, 2012.

Related products

Skip to content